These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques. Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786 [TBL] [Abstract][Full Text] [Related]
5. [The value of (18)F-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET-CT) in evaluating the stability of atherosclerotic plaques]. Zhang YH; Tian P; Xu JP; Wang ZZ; Zhao XZ; Nie MX; Zhang MD; Zhao QM; Zhao BT; Song SJ Zhonghua Nei Ke Za Zhi; 2019 Nov; 58(11):808-813. PubMed ID: 31665855 [No Abstract] [Full Text] [Related]
6. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602 [TBL] [Abstract][Full Text] [Related]
7. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186 [TBL] [Abstract][Full Text] [Related]
9. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. Tawakol A; Migrino RQ; Hoffmann U; Abbara S; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ J Nucl Cardiol; 2005; 12(3):294-301. PubMed ID: 15944534 [TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system. Li X; Heber D; Rausch I; Beitzke D; Mayerhoefer ME; Rasul S; Kreissl M; Mitthauser M; Wadsak W; Hartenbach M; Haug A; Zhang X; Loewe C; Beyer T; Hacker M Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1503-12. PubMed ID: 26816195 [TBL] [Abstract][Full Text] [Related]
11. Detection of vulnerable atherosclerotic plaque and prediction of thrombosis events in a rabbit model using 18F-FDG -PET/CT. Zhao QM; Zhao X; Feng TT; Zhang MD; Zhuang XC; Zhao XC; Li LQ; Li DP; Liu Y PLoS One; 2013; 8(4):e61140. PubMed ID: 23613798 [TBL] [Abstract][Full Text] [Related]
12. High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging. Hyafil F; Schindler A; Sepp D; Obenhuber T; Bayer-Karpinska A; Boeckh-Behrens T; Höhn S; Hacker M; Nekolla SG; Rominger A; Dichgans M; Schwaiger M; Saam T; Poppert H Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):270-279. PubMed ID: 26433367 [TBL] [Abstract][Full Text] [Related]
13. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study. Derlin T; Tóth Z; Papp L; Wisotzki C; Apostolova I; Habermann CR; Mester J; Klutmann S J Nucl Med; 2011 Jul; 52(7):1020-7. PubMed ID: 21680686 [TBL] [Abstract][Full Text] [Related]
14. [Noninvasive imaging of vulnerable plaques and thromboses with PET/CT complex imaging technique]. Zhao X; Zhao QM; Feng TT; Li DP; Liu Y; Li LQ; Zhang MD; Zhuang XC; Zhao XC Zhonghua Yi Xue Za Zhi; 2013 May; 93(19):1454-7. PubMed ID: 24029566 [TBL] [Abstract][Full Text] [Related]
15. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582 [TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine. Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231 [TBL] [Abstract][Full Text] [Related]
19. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner. Millon A; Dickson SD; Klink A; Izquierdo-Garcia D; Bini J; Lancelot E; Ballet S; Robert P; Mateo de Castro J; Corot C; Fayad ZA Atherosclerosis; 2013 Jun; 228(2):339-45. PubMed ID: 23582588 [TBL] [Abstract][Full Text] [Related]
20. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT. Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]